Steffi Silling Ulrike Wieland Marko Werner Herbert Pfister Anja Potthoff Alexander Kreuter
10.3201/eid2001.130999
Emerg Infect Dis
2014 Jan;20(1):142-5.
hpv hpv vaccination hpvxs2 human papillomavirus immunosuppressed novel human papillomavirus papillomavirus quadrivalent hpv vaccine vaccination viruses warts
CC BY
https://pubmed.ncbi.nlm.nih.gov/24378072/
Alphapapillomavirus / immunology Papillomavirus Vaccines / immunology Vaccination Warts / prevention & control
Alphapapillomavirus / immunology Papillomavirus Vaccines / immunology Vaccination Warts / prevention & control Case Reports Research Support, Non-U.S. Gov't Adult Alphapapillomavirus / classification Alphapapillomavirus / genetics Antineoplastic Combined Chemotherapy Protocols / adverse effects Antineoplastic Combined Chemotherapy Protocols / therapeutic use Capsid Proteins / genetics DNA, Viral Female Humans Immunocompromised Host Leukemia, Lymphocytic, Chronic, B-Cell / complications Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy Molecular Sequence Data Phylogeny Skin / pathology Skin / virology Warts / complications Warts / diagnosis Warts / immunology Capsid Proteins DNA, Viral Papillomavirus Vaccines
PMC3884730
24378072
Resolution of novel human papillomavirus-induced warts after HPV vaccination
2014